Webinars

Topic: Physics-Driven Discovery of SNX281, a Novel Small Molecule Sting Agonist in Clinical Trials for Solid Tumors or Lymphoma
Presenter: Woody Sherman, Ph.D., Silicon Therapeutics


Host: Jason Key

Recorded on March 23, 2021